摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(benzoylureido)piperidine | 72807-00-2

中文名称
——
中文别名
——
英文名称
4-(benzoylureido)piperidine
英文别名
1-Benzoyl-3-(piperid-4-yl)urea;4-Benzoylureidopiperidine;N-(piperidin-4-ylcarbamoyl)benzamide
4-(benzoylureido)piperidine化学式
CAS
72807-00-2
化学式
C13H17N3O2
mdl
——
分子量
247.297
InChiKey
VDPTZNWSWWZWNC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.21±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    70.2
  • 氢给体数:
    3
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Antihypertensive ureidopiperidines
    作者:J. L. Archibald、D. R. Beardsley、G. M. F. Bisset、P. Fairbrother、J. L. Jackson、A. Opalko、T. J. Ward
    DOI:10.1021/jm00182a009
    日期:1980.8
    These compounds are related to the benzamidopiperidines exemplified by indoramin. Some of the ureidopiperidines are more potent antihypertensive agents than their benzamidopiperidine counterparts. Two examples, 1-(2-thenoyl)-3-[1-[2-(3-indolyl)ethyl]piperid-4-yl]urea and 1-(2-thenoyl)-3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperid-4-yl]urea (19 and 58), emerged as the most potent antihypertensive agents
    报道了一系列1-芳烷基-4-哌啶的合成。这些化合物与吲哚胺为例的苯甲酰哌啶有关。一些哌啶比其苯甲酰哌啶具有更强的抗高血压药。两个例子,1-(2-thenoyl)-3- [1- [2-(3-吲哚基)乙基]哌啶-4-基]和1-(2-thenoyl)-3- [1- [4- (4-氟苯基)-4-氧代丁基]哌啶-4-基](19和58)成为本系列中最有效的降压药。
  • Piperid-4-yl ureas and thio ureas used as anti-depressant agents
    申请人:John Wyeth & Brother Ltd.
    公开号:US04426387A1
    公开(公告)日:1984-01-17
    The invention concerns compounds of formula ##STR1## and acid addition and quaternary ammonium salts thereof, wherein the dotted line represents an optional bond, Ar represents a ring system of formula ##STR2## in which Q is O,S,--CR.sup.7 .dbd.CR.sup.8 --, --N.dbd.CR.sup.8 -- and --N.dbd.N--; R.sup.4, R.sup.5 and R.sup.6, and R.sup.7 and R.sup.8 when present, each represent hydrogen or defined substituents and additionally either R.sup.4 and R.sup.5 when adjacent or R.sup.6 and R.sup.8 when adjacent, together with the carbon atoms to which they are attached also represent a fused five or six membered carbocyclic or heterocyclic ring optionally carrying one or more defined substituents; R is an optionally substituted aryl or heteroaryl radical or a cycloalkyl radical containing 5 to 7 carbon atoms; R.sup.1, R.sup.2, R.sup.3 and R.sup.9 are each hydrogen or a lower alkyl group; n is 0 or 1; X is .dbd.O, .dbd.S or .dbd.NH; Y is --O-- or a direct bond and Z is --CO-- or --CH.sub.2 -- with the proviso that when Ar is unsubstituted phenyl and R.sup.9 is hydrogen then Y is --O--. The compounds of formula I exhibit psychotropic activity and are useful as antidepressants. Processes for preparing the compounds and pharmaceutical compositions containing them are disclosed.
    本发明涉及公式##STR1##的化合物及其酸加成物和季盐,其中点线表示可选键,Ar表示式##STR2##的环系统,其中Q为O、S、-CR.sup.7 =CR.sup.8-、-N=CR.sup.8-和-N=N-;R.sup.4、R.sup.5和R.sup.6,以及当存在时,R.sup.7和R.sup.8每个表示氢或定义的取代基,并且当相邻的R.sup.4和R.sup.5或相邻的R.sup.6和R.sup.8与它们连接的碳原子一起也表示融合的五元或六元碳环或杂环,可选地携带一个或多个定义的取代基;R是可选地取代的芳基或杂芳基基团或含有5到7个碳原子的环烷基基团;R.sup.1、R.sup.2、R.sup.3和R.sup.9分别是氢或较低的烷基基团;n为0或1;X为.dbd.O、.dbd.S或.dbd.NH;Y为--O--或直接键,Z为--CO--或--CH.sub.2--,但当Ar为未取代的苯基且R.sup.9为氢时,Y为--O--。公式I的化合物具有精神药物活性,并可用作抗抑郁剂。公开了制备这些化合物和含有它们的制药组合物的方法。
  • Anti-depressant indole derivatives
    申请人:John Wyeth & Brother Limited
    公开号:US04209521A1
    公开(公告)日:1980-06-24
    The invention concerns a compound of formula II ##STR1## or a pharmaceutically acceptable acid addition or quaternary ammonium salt thereof wherein R.sup.5 represents hydrogen, hydroxy, lower alkoxy or lower alkyl, R.sup.6 represents hydrogen or lower alkyl, and R.sup.7 represents phenyl, lower alkoxy phenyl, halophenyl, or thenyl and X represents oxygen or sulphur. These indole derivatives exhibit psychotropic activity. The invention includes a method of alleviating depression in a warm blooded animal afflicted with depression which method comprises administering to said animal an effective amount of a compound of formula II or a pharmaceutically acceptable acid addition salt thereof.
    本发明涉及II式化合物,其中R.sup.5代表氢,羟基,较低的烷氧基或较低的烷基;R.sup.6代表氢或较低的烷基;R.sup.7代表苯基,较低的烷氧基苯基,卤代苯基或基;X代表氧或。这些吲哚生物具有精神活性。本发明包括一种方法,用于缓解患有抑郁症的温血动物的抑郁症状,该方法包括向该动物施用II式化合物或其药学上可接受的酸加成盐的有效量。
  • 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and
    申请人:John Wyeth and Brother Limited
    公开号:US04722930A1
    公开(公告)日:1988-02-02
    The invention concerns the preparation of compounds of formula ##STR1## and acid addition and quaternary ammonium salts thereof, wherein the dotted line represents an optional bond, Ar represents a ring system of formula ##STR2## in which Q is O, S, --CR.sup.7 .dbd.CR.sup.8 --, --N.dbd.CR.sup.8 -- and --N.dbd.N--; R.sup.4, R.sup.5 and R.sup.6, and R.sup.7 and R.sup.8 when present, each represent hydrogen or a substituent selected from lower alkyl, lower alkenyl, lower alkoxy, NO.sub.2, NH.sub.2, haloloweralkyl, hydroxyloweralkyl, aminoloweralkyl, substituted amino, halogen, loweralkoxycarbonyl, cyano, CONH.sub.2 and hydroxy; and additionally either R.sup.4 and R.sup.5 when adjacent or R.sup.6 and R.sup.8 when adjacent, together with the carbon atoms to which they are attached also represent a fused five or six membered carbocylic or heterocyclic ring optionally carrying one or more substituents as defined above; R is an optionally substituted aryl or heteroaryl radical or a cycloalkyl radical containing 5 to 7 carbon atoms; R.sup.1, R.sup.2, R.sup.3 and R.sup.9 are each hydrogen or a lower alkyl group; n is 0 or 1, X is .dbd.O, .dbd.S or .dbd.NH; Y is --O-- or a direct bond and Z is -- CO-- or --CH.sub.2 --, with the proviso that when Ar is unsubstituted phenyl and R.sup.9 is hydrogen then Y is --O--. The compounds of formula I exhibit psychotropic activity and are useful as antidepressants.
    本发明涉及公式##STR1##化合物的制备,以及其酸加成物和季盐,其中点线表示可选键,Ar表示公式##STR2##的环系统,其中Q为O,S,-CR.sup.7 =CR.sup.8 -,-N=CR.sup.8 -和-N=N-; 当存在时,R.sup.4,R.sup.5和R.sup.6,以及R.sup.7和R.sup.8,均表示氢或从较低的烷基,较低的烯基,较低的烷氧基,NO.sub.2,NH.sub.2,卤代较低烷基,羟基较低烷基,基较低烷基,取代基,卤素,较低烷氧羰基,基,CONH.sub.2和羟基中选择的取代基; 另外,当相邻的R.sup.4和R.sup.5或R.sup.6和R.sup.8存在时,它们与它们所附着的碳原子一起也表示一个融合的五元或六元环或杂环,可选地携带一个或多个上述定义的取代基; R是一个可选地取代的芳基或杂环芳基基团或含有5到7个碳原子的环烷基基团; R.sup.1,R.sup.2,R.sup.3和R.sup.9分别为氢或较低烷基; n为0或1,X为.dbd.O,.dbd.S或.dbd.NH; Y为-O-或直接键,Z为-CO-或-CH.sub.2-,但是当Ar为未取代的苯丙基且R.sup.9为氢时,Y为-O-。公式I的化合物具有精神活性,并可用作抗抑郁剂。
  • Pyridyl-and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
    申请人:John Wyeth & Brother, Limited
    公开号:US04985438A1
    公开(公告)日:1991-01-15
    The invention concerns the preparation of compounds of formula ##STR1## and acid addition and quaternary ammonium salts thereof, wherein the dotted line represents an optional bond, Ar represents a ring system of formula ##STR2## in which Q is O, S, --CR.sup.7 .dbd.CR.sup.8 --, --N.dbd.CR.sup.8 -- and --N.dbd.N--; R.sup.4, R.sup.5 and R.sup.6 ; and R.sup.7 and R.sup.8 when present, each represent hydrogen or a substitutent selected from lower alkyl, lower alkenyl, lower alkoxy, NO.sub.2, NH.sub.2, haloloweralkyl, hydroxyloweralkyl, aminoloweralkyl, substituted amino, halogen, loweralkoxycarbonyl, cyano, CONH.sub.2 and hydroxy; and additionally either R.sup.4 and R.sup.5 when adjacent or R.sup.6 and R.sup.8 when adjacent, together with the carbon atoms to which they are attached also represent a fused five or six membered carbocylic or heterocyclic ring optionally carrying one or more substituents as defined above; R is an optionally substituted aryl or heteroaryl radical or a cycloalkyl radical containing 5 to 7 carbon atoms; R.sup.1, R.sup.2, R.sup.3 and R.sup.9 are each hydrogen or a lower alkyl group; n is 0 or 1; X is .dbd.O, .dbd.S or .dbd.NH; Y is--O-- or a direct bond and Z is --CO-- or --CH.sub.2 --, with the proviso that when Ar is unsubstituted phenyl and R.sup.9 is hydrogen then y is --O--. The compounds of formula I exhibit psychotropic activity and are useful as antidepressants.
    本发明涉及公式##STR1##化合物及其酸加成物和季盐的制备方法,其中点线表示可选键,Ar表示公式##STR2##的环系统,其中Q为O、S、--CR.sup.7 .dbd.CR.sup.8 --、--N.dbd.CR.sup.8 --和--N.dbd.N--;R.sup.4、R.sup.5和R.sup.6;当存在时,R.sup.7和R.sup.8各自表示氢或从下列取出的取代基:低烷基、低烯基、低烷氧基、NO.sub.2、NH.sub.2、卤代低烷基、羟基低烷基、基低烷基、取代基、卤素、低烷氧羰基、基、CONH.sub.2和羟基;并且在相邻的R.sup.4和R.sup.5或R.sup.6和R.sup.8之间,连同它们附着的碳原子,也表示一个融合的五元或六元碳环或杂环,可选地携带一个或多个上述定义的取代基;R是一个可选取代的芳基或杂环芳基基团或含有5到7个碳原子的环烷基基团;R.sup.1、R.sup.2、R.sup.3和R.sup.9各自表示氢或低烷基;n为0或1;X为.dbd.O、.dbd.S或.dbd.NH;Y为--O--或直接键,Z为--CO--或--CH.sub.2 --,但前提是当Ar为未取代的苯基且R.sup.9为氢时,y为--O--。公式I的化合物表现出精神活性并可用作抗抑郁剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫